News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Phase Genomics Advances Breakthrough Cytogenomics with the Element AVITI System for Acute Myeloid Leukemia
Seattle-based biotech company Phase Genomics released new data from its OncoTerra platform and ATIVI sequencing system, which aim to provide innovative, rapid risk assessment for
Biotech around the World: The West Coast of the United States
GEN, Genetic Engineering & Biotechnology News, begins its Biotech around the World series with a feature on the West Coast of the United States. Through
University of Wash. Bothell and Cascadia College celebrate new STEM-focused Innovation Hall
The University of Washington Bothell and Cascadia College announced at a celebratory event their shared Innovation Hall, which will support students specializing in chemistry, computer
New website helps engineers find biomedical challenges that crown winning algorithms
Seattle nonprofit Sage Bionetworks released a new site called OpenChallenges that allows users to post biomedical challenges and potential algorithmic solutions. The free site meets
Lincoln Property Company’s Nearly 200,000 SQFT Life Science Building in Seattle Tops Out
Lincoln Property Company (LPC) and Intercontinental Real Estate Corporation celebrated the topping out of a new life science building in Seattle. Located at 222 Fifth
US FDA approves Bristol-Myers’ lung cancer drug
Pharmaceutical company Bristol-Myers Squibb received FDA approval for Augtyro, a drug developed to treat lung cancer. The approval comes after the drug, was successful in
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis
Seattle-based company Sana Biotechnology (Sana) received FDA clearance for its Investigational New Drug application aimed at treating “patients with multiple B-cell mediated autoimmune diseases,” according
Alpine Immune Sciences raising $150M through public offering
Alpine Immune Sciences Inc., a biotech company based in Seattle, has raised $150 million through underwritten public funding. According to Alpine, the new funding brings
BioLife Solutions raises $10.4M through private placement
BioLife Solutions Inc., a biological material storage business based in Bothell, Washington, received $10.4 million in funding from Casdin Capital, an investment firm based out
Novartis’ $3.2B Chinook Buy Pays Off with Promising Phase III IgAN Data
Seattle-based Chinook Therapeutics, purchased earlier this year by Swiss pharmaceutical company Novartis, announced a successful Phase III ALIGN study with its drug, atrasentan. Atrasentan, intended
Gut microbiome startup Viome buys digital wellness startup Naring Health
Bellevue-based biotech company Viome Life Sciences acquired Naring Health, a startup company specializing in “personalized nutrition.” While specific details have not been disclosed, Viome will
Selkirk Pharma raises $24M in seed funding
Selkirk Pharma, a Spokane-based startup, raised $24.1 million to support its development of sterile therapeutics. The funding, which came from unnamed investors, brings Selkirk’s total